Nice new work by Larissa Rizzo, Federica de Lorenzi et al in @cp-cellreports.bsky.social on nanomedicine targeting to metastases 🎯

👉 www.cell.com/cell-reports...

When 1+1 > 2 ✌️

In this Analysis, we show that (1) nanomedicines are useful to improve the efficacy of multi-drug cancer therapy, and that (2) co-delivering two drugs in one NP produces better outcomes than co-administering two single-drug-loaded NP

👉 rdcu.be/el86N

Very nice new work by Tarun Ojha et al. on the use of dexamethasone nanomedicines to target SPP1-macrophages and reduce tumor fibrosis

www.cell.com/cell-biomate...

Honored and happy to be (s)elected as a fellow of @aimbe-official.bsky.social 🇺🇸

Many thanks to my nominator and the professorial photographer 📸

On the essence of academic studies, teaching, training and research 👇

First paper of 2025.

Great work by Karina Benderski, Paul Schneider et al, in the framework of #SFB1066 @dfgpublic.bsky.social 👌

Note also our upcoming symposium on Jan 24-25, registration still possible 👉

sfb1066.de/en/internati...

Had a great time in Seoul attending KSPST 2024

Thanks to the organizers for inviting me and for involving the Korean Chapter of the CRS

Very much appreciate the kindness, welcoming atmosphere, hospitality, lovely dinners, and long-lasting friendships, including with several editors of JCR

Join us at CRS Singapore in Feb 2025 🇸🇬

Note the abstract deadline : Dec 1 📝

Meet our global leaders & local experts 👉

www.controlledreleasesociety.org/events/crsin...